Cargando…

CRISPR-CasRx Targeting LncRNA LINC00341 Inhibits Tumor Cell Growth in vitro and in vivo

CRISPR-CasRx technology provides a new and powerful method for studying cellular RNA in human cancer. Herein, the pattern of expression of long noncoding RNA 00341 (LINC00341) as well as its biological function in bladder cancer were studied using CRISPR-CasRx. qRT-PCR was employed to quantify the l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chunjing, Cao, Yu, Zhang, Li, Li, Jierong, Wang, Jianfeng, Zhou, Yanfen, Wei, Huiling, Guo, Mingjuan, Liu, Liang, Liu, Chunxiao, Zhang, Shilin, Liu, Guoqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040045/ https://www.ncbi.nlm.nih.gov/pubmed/33855047 http://dx.doi.org/10.3389/fmolb.2021.638995

Ejemplares similares

Methods for in vitro CRISPR/CasRx-Mediated RNA Editing
por: Chuang, Yu-Fan, et al.
Publicado: (2021)

Engineered Extracellular Vesicle‐Delivered CRISPR/CasRx as a Novel RNA Editing Tool
por: Li, Tianwen, et al.
Publicado: (2023)

Relationship between LINC00341 expression and cancer prognosis
por: Liao, Meijian, et al.
Publicado: (2017)

Programmable RNA Targeting Using CasRx in Flies
por: Buchman, Anna B., et al.
Publicado: (2020)

Precise and efficient silencing of mutant Kras(G12D) by CRISPR-CasRx controls pancreatic cancer progression
por: Jiang, Wang, et al.
Publicado: (2020)

Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing
por: Zheng, Ziwen, et al.
Publicado: (2022)

Specific knockdown of Htra2 by CRISPR-CasRx prevents acquired sensorineural hearing loss in mice
por: Guo, Yang, et al.
Publicado: (2022)

Enhanced RNA knockdown efficiency with engineered fusion guide RNAs that function with both CRISPR-CasRx and hammerhead ribozyme
por: Zhan, Yonghao, et al.
Publicado: (2023)

CRISPR/CasRx Proof-of-Concept for RNA Degradation: A Future Tool against RNA Viruses?
por: Perez-SanJose, Diana, et al.
Publicado: (2021)

Knockdown of Long Non-coding RNA SNGH3 by CRISPR-dCas9 Inhibits the Progression of Bladder Cancer
por: Cao, Yu, et al.
Publicado: (2021)

CRISPR/CasRx-Mediated RNA Knockdown Reveals That ACE2 Is Involved in the Regulation of Oligodendroglial Cell Morphological Differentiation
por: Kato, Yukino, et al.
Publicado: (2022)

RNA targeting using CasRx can prevent aminoglycoside-induced hearing loss
por: Bofill-De Ros, Xavier
Publicado: (2022)

A Sensitive, Rapid, and Portable CasRx-based Diagnostic Assay for SARS-CoV-2
por: Brogan, Daniel J, et al.
Publicado: (2020)

The long noncoding RNA LINC00341 suppresses colorectal carcinoma by preventing cell migration and apoptosis
por: Li, Shuyuan, et al.
Publicado: (2020)

CasRx-mediated RNA targeting prevents choroidal neovascularization in a mouse model of age-related macular degeneration
por: Zhou, Changyang, et al.
Publicado: (2020)

Evaluating the Impact of gRNA SNPs in CasRx Activity for Reducing Viral RNA in HCoV-OC43
por: Mayes, Cathryn Michelle, et al.
Publicado: (2022)

Risk factors of uterine contraction after ureteroscopy in pregnant women with renal colic
por: Li, Chunjing, et al.
Publicado: (2021)

LncRNA IGFBP4-1 promotes tumor development by activating Janus kinase-signal transducer and activator of transcription pathway in bladder urothelial carcinoma
por: Li, Chunjing, et al.
Publicado: (2020)

LncRNA IGFBP4-1 promotes tumor development by activating Janus kinase-signal transducer and activator of transcription pathway in bladder urothelial carcinoma: retraction
por: Li, Chunjing, et al.
Publicado: (2023)

Application of Ureteroscope in Emergency Treatment with Persistent Renal Colic Patients during Pregnancy
por: Zhang, Shilin, et al.
Publicado: (2016)

Clinical implications of lncRNA LINC-PINT in cancer
por: Bukhari, Ihtisham, et al.
Publicado: (2023)

Pan-Coronavirus CRISPR-CasRx Effector System Significantly Reduces Viable Titer in HCoV-OC43, HCoV-229E, and SARS-CoV-2
por: Mayes, Cathryn M., et al.
Publicado: (2023)

Homology-directed repair in mouse cells increased by CasRx-mediated knockdown or co-expressing Kaposi’s sarcoma-associated herpesvirus ORF52
por: Pan, Hong, et al.
Publicado: (2019)

Transcriptional Inhibition of lncRNA gadd7 by CRISPR/dCas9-KRAB Protects Spermatocyte Viability
por: Zhao, Jun, et al.
Publicado: (2021)

Knockdown of LncRNA PANDAR by CRISPR-dCas9 Decreases Proliferation and Increases Apoptosis in Oral Squamous Cell Carcinoma
por: Jia, Tingting, et al.
Publicado: (2021)

Evaluation of the clinical value of retroperitoneal laparoscopic pyeloplasty in the treatment of ureteropelvic junction obstruction in infants: A single-center experience involving 22 consecutive patients
por: Zhang, Shilin, et al.
Publicado: (2019)

LncRNA LINC00944 Promotes Tumorigenesis but Suppresses Akt Phosphorylation in Renal Cell Carcinoma
por: Chen, Chiheng, et al.
Publicado: (2021)

Enhancement of protein translation by CRISPR/dCasRx coupled with SINEB2 repeat of noncoding RNAs
por: Cao, Congcong, et al.
Publicado: (2023)

Structural and functional characterization of Cas2 of CRISPR-Cas subtype I-C lacking the CRISPR component
por: Anand, Vineet, et al.
Publicado: (2022)

Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-β/Smad Signaling
por: Zhuang, Changshui, et al.
Publicado: (2020)

Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid
por: Li, Xiaoping, et al.
Publicado: (2023)

Corrigendum: Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-β/Smad Signaling
por: Zhuang, Changshui, et al.
Publicado: (2021)

lncRNA SNHG9 Promotes Cell Proliferation, Migration, and Invasion in Human Hepatocellular Carcinoma Cells by Increasing GSTP1 Methylation, as Revealed by CRISPR-dCas9
por: Ye, Shanting, et al.
Publicado: (2021)

Synthetic Artificial Long Non-coding RNA Shows Higher Efficiency in Specific Malignant Phenotype Inhibition Compared to the CRISPR/Cas Systems
por: Yao, Lin, et al.
Publicado: (2020)

A Small RNA Is Linking CRISPR–Cas and Zinc Transport
por: Märkle, Pascal, et al.
Publicado: (2021)

Identification of a prognostic classifier based on EMT-related lncRNAs and the function of LINC01138 in tumor progression for lung adenocarcinoma
por: Xiao, Lingyan, et al.
Publicado: (2022)

CRISPR-Cas13-Mediated Knockdown of lncRNA-GACAT3 Inhibited Cell Proliferation and Motility, and Induced Apoptosis by Increasing p21, Bax, and E-Cadherin Expression in Bladder Cancer
por: Zhang, Zhongfu, et al.
Publicado: (2021)

Identification of UBE2I as a Novel Biomarker in ccRCC Based on a Large-Scale CRISPR-Cas9 Screening Database and Immunohistochemistry
por: Li, Feng, et al.
Publicado: (2022)

Pacbio Sequencing of PLC/PRF/5 Cell Line and Clearance of HBV Integration Through CRISPR/Cas-9 System
por: Chen, Chia-Chen, et al.
Publicado: (2021)

LINC02257, an Enhancer RNA of Prognostic Value in Colon Adenocarcinoma, Correlates With Multi-Omics Immunotherapy-Related Analysis in 33 Cancers
por: Xiao, Junbo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1e9am2vfk52l3bm2n6sm69rbvp